• Home    Login    Register    Live    Top users    Tag cloud   

• Published News
• Upcoming News
• Submit a new story

• Stuffdaily - News and Article Directory Home » User » acomplia » Submitted

• Sort news by: Recently Popular | Top Today | Yesterday | Week | Month | Year |

acomplia / Submitted

• 3
• Vote

acomplia rimonabant zimulti

Posted by acomplia 413 days ago (http://acomplia.smyr.net) View profile
Category: Health and Disease | Tags: acomplia rimonabant

LONDON, May 8 (newratings.com) - Analysts at JP Morgan reiterate their "overweight" rating on Sanofi-Aventis SA (SNW.ETR), while raising their estimates for the company. The 12-month target price is set to €78.

In a research note published this morning, the analysts mention that the company has reported robust 1Q results, with sales in-line with the consensus. Sanofi-Aventis has raised its profit guidance for FY07. The analysts believe, however, that the company has raised its guidance con read more »
Discuss   Add this link to...  Tell a friend   Bury
Add to:      
In a research note published this morning, the analysts mention that the company has reported robust 1Q results, with sales in-line with the consensus. Sanofi-Aventis has raised its profit guidance for FY07. The analysts believe, however, that the company has raised its guidance con">            |   Bookmarks